Molecular Data Inc. American Depositary Shares
MKD was delisted on the 6th of September, 2022.
1 hedge funds and large institutions have $482 invested in Molecular Data Inc. American Depositary Shares in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
50% less funds holding
Funds holding: 2 → 1 (-1)
76% less capital invested
Capital invested by funds: $2K → $482 (-$1.52K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$124 |
Top Sellers
MKD Hedge Fund Activity: Q4 2022 in Review
1 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Molecular Data Inc. American Depositary Shares (MKD) for Q4 2022, worth a combined $482 — down 76% from $2K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of MKD and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.
The largest buyer was Sabby Management, adding an estimated $124.
- 1 institutional investor held Molecular Data Inc. American Depositary Shares (MKD) as of Q4 2022, down from 2 in Q3 2022.
- Funds reported $482 of Molecular Data Inc. American Depositary Shares stock for Q4 2022, down 76% quarter-over-quarter.
- 0 funds opened new Molecular Data Inc. American Depositary Shares positions in Q4 2022 and 1 closed out, a net change of -1 holder.
- The largest Molecular Data Inc. American Depositary Shares buyer in Q4 2022 was Sabby Management, an estimated $124 added.
Based on aggregated 13F filings for Q4 2022.